Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy

NCT01562821 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

235

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Bleeding Disorder
Cirrhosis

Interventions

DRUG: activated recombinant human factor VII
DRUG: activated recombinant human factor VII
DRUG: placebo

Sponsor

Novo Nordisk A/S